Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Celgene Corp (NASDAQ:CELG)

99.59
Delayed Data
As of Feb 11
 -3.57 / -3.46%
Today’s Change
92.98
Today|||52-Week Range
140.72
-16.84%
Year-to-Date

Today’s Trading

Previous close103.16
Today’s open100.21
Day’s range98.36 - 102.15
Volume7,519,510
Average volume (3 months)5,798,994
Market cap$81.0B
Dividend yield--
Data as of 4:00pm ET, 02/11/2016

Growth & Valuation

Earnings growth (last year)-18.83%
Earnings growth (this year)+20.53%
Earnings growth (next 5 years)+23.00%
Revenue growth (last year)+21.11%
P/E ratio49.9
Price/Sales10.67
Price/Book--

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co-1.65-2.26%
ABBVAbbVie-0.54-1.02%
AZNAstraZeneca+0.11+0.38%
GSKGlaxoSmithKline+0.02+0.05%
Data as of 4:05pm ET, 02/11/2016

Financials

Next reporting dateApril 21, 2016
EPS forecast (this quarter)$1.27
Annual revenue (last year)$9.3B
Annual profit (last year)$1.6B
Net profit margin17.31%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert J. Hugin
President &
Chief Operating Officer
Mark J. Alles
Corporate headquarters
Summit, New Jersey

Forecasts

Partner Offers